• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高多基因风险分类的不稳定性及通过综合评分进行缓解

Instability of high polygenic risk classification and mitigation by integrative scoring.

作者信息

Misra Anika, Truong Buu, Urbut Sarah M, Sui Yang, Fahed Akl C, Smoller Jordan W, Patel Aniruddh P, Natarajan Pradeep

机构信息

Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Center for Genomic Medicine and Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.

出版信息

Nat Commun. 2025 Feb 12;16(1):1584. doi: 10.1038/s41467-025-56945-0.

DOI:10.1038/s41467-025-56945-0
PMID:39939586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11822040/
Abstract

Polygenic risk scores (PRS) continue to improve with novel methods and expanding genome-wide association studies. Healthcare and commercial laboratories are increasingly deploying PRS reports to patients, but it is unknown how the classification of high polygenic risk changes across individual PRS. Here, we assess the association and classification performance of cataloged PRS for three complex traits. We chronologically order all trait-related publications (Pub) and identify the single PRS Best(Pub) for each Pub that has the strongest association with the target outcome. While each Best(Pub) demonstrates generally consistent population-level strengths of associations, the classification of individuals in the top 10% of each Best(Pub) distribution varies widely. Using the PRSmix framework, which integrates information across several PRS to improve prediction, we generate corresponding ChronoAdd(Pub) scores for each Pub that combine all polygenic scores from all publications up to and including Pub. When compared with Best(Pub), ChronoAdd(Pub) scores demonstrate more consistent high-risk classification amongst themselves. This integrative scoring approach provides stable and reliable classification of high-risk individuals and is an adaptable framework into which new scores can be incorporated as they are introduced, integrating easily with current PRS implementation strategies.

摘要

多基因风险评分(PRS)随着新方法的出现和全基因组关联研究的扩展而不断改进。医疗保健和商业实验室越来越多地向患者提供PRS报告,但目前尚不清楚高多基因风险的分类在各个PRS之间是如何变化的。在这里,我们评估了已编目的PRS对三种复杂性状的关联和分类性能。我们按时间顺序排列所有与性状相关的出版物(Pub),并为每个与目标结果关联最强的Pub确定单个最佳PRS(Best(Pub))。虽然每个Best(Pub)在总体人群水平上显示出大致一致的关联强度,但每个Best(Pub)分布中前10%个体的分类差异很大。使用PRS混合框架,该框架整合多个PRS的信息以提高预测能力,我们为每个Pub生成相应的ChronoAdd(Pub)分数,该分数结合了直至并包括该Pub的所有出版物的所有多基因分数。与Best(Pub)相比,ChronoAdd(Pub)分数在它们自身之间表现出更一致的高风险分类。这种综合评分方法为高风险个体提供了稳定可靠的分类,并且是一个适应性框架,新分数引入时可以纳入其中,能够轻松地与当前的PRS实施策略相结合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3c4/11822040/76c54fdb6849/41467_2025_56945_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3c4/11822040/24048e7faa27/41467_2025_56945_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3c4/11822040/890dbbe1227b/41467_2025_56945_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3c4/11822040/617a4d9979ea/41467_2025_56945_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3c4/11822040/334b3b221856/41467_2025_56945_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3c4/11822040/392f5b07f6da/41467_2025_56945_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3c4/11822040/6942cb59f157/41467_2025_56945_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3c4/11822040/faf2727ad171/41467_2025_56945_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3c4/11822040/eaa40b229684/41467_2025_56945_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3c4/11822040/76c54fdb6849/41467_2025_56945_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3c4/11822040/24048e7faa27/41467_2025_56945_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3c4/11822040/890dbbe1227b/41467_2025_56945_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3c4/11822040/617a4d9979ea/41467_2025_56945_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3c4/11822040/334b3b221856/41467_2025_56945_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3c4/11822040/392f5b07f6da/41467_2025_56945_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3c4/11822040/6942cb59f157/41467_2025_56945_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3c4/11822040/faf2727ad171/41467_2025_56945_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3c4/11822040/eaa40b229684/41467_2025_56945_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3c4/11822040/76c54fdb6849/41467_2025_56945_Fig9_HTML.jpg

相似文献

1
Instability of high polygenic risk classification and mitigation by integrative scoring.高多基因风险分类的不稳定性及通过综合评分进行缓解
Nat Commun. 2025 Feb 12;16(1):1584. doi: 10.1038/s41467-025-56945-0.
2
Instability of high polygenic risk classification and mitigation by integrative scoring.高多基因风险分类的不稳定性及通过综合评分进行缓解
medRxiv. 2024 Oct 28:2024.07.24.24310897. doi: 10.1101/2024.07.24.24310897.
3
A principal component approach to improve association testing with polygenic risk scores.一种基于主成分分析的方法,用于提高基于多基因风险评分的关联分析。
Genet Epidemiol. 2020 Oct;44(7):676-686. doi: 10.1002/gepi.22339. Epub 2020 Jul 21.
4
Efficient Implementation of Penalized Regression for Genetic Risk Prediction.高效实现基于惩罚回归的遗传风险预测。
Genetics. 2019 May;212(1):65-74. doi: 10.1534/genetics.119.302019. Epub 2019 Feb 26.
5
On polygenic risk scores for complex traits prediction.基于多基因风险评分的复杂性状预测。
Biometrics. 2022 Jun;78(2):499-511. doi: 10.1111/biom.13466. Epub 2021 Apr 27.
6
Pharmacogenomics polygenic risk score for drug response prediction using PRS-PGx methods.基于 PRS-PGx 方法的药物反应预测的药物基因组多基因风险评分。
Nat Commun. 2022 Sep 8;13(1):5278. doi: 10.1038/s41467-022-32407-9.
7
Polygenic risk and hazard scores for Alzheimer's disease prediction.多基因风险和阿尔茨海默病预测的危害评分。
Ann Clin Transl Neurol. 2019 Feb 18;6(3):456-465. doi: 10.1002/acn3.716. eCollection 2019 Mar.
8
Challenges and Opportunities for Developing More Generalizable Polygenic Risk Scores.开发更具泛化能力的多基因风险评分的挑战与机遇。
Annu Rev Biomed Data Sci. 2022 Aug 10;5:293-320. doi: 10.1146/annurev-biodatasci-111721-074830. Epub 2022 May 16.
9
Benchmarking Alzheimer's disease prediction: personalised risk assessment using polygenic risk scores across various methodologies and genome-wide studies.阿尔茨海默病预测的基准测试:使用跨多种方法和全基因组研究的多基因风险评分进行个性化风险评估。
Alzheimers Res Ther. 2025 Jan 6;17(1):6. doi: 10.1186/s13195-024-01664-9.
10
Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.基于人群的前瞻性队列研究:东亚常见癌症的多基因风险评分预测。
Elife. 2023 Mar 27;12:e82608. doi: 10.7554/eLife.82608.

引用本文的文献

1
Diabetes mellitus polygenic risk scores: heterogeneity and clinical translation.糖尿病多基因风险评分:异质性与临床转化。
Nat Rev Endocrinol. 2025 Jun 4. doi: 10.1038/s41574-025-01132-w.
2
Precision Medicine in Cardiovascular Disease Prevention: Clinical Validation of Multi-Ancestry Polygenic Risk Scores in a U.S. Cohort.心血管疾病预防中的精准医学:美国队列中多血统多基因风险评分的临床验证
Nutrients. 2025 Mar 6;17(5):926. doi: 10.3390/nu17050926.

本文引用的文献

1
Evaluating Performance and Agreement of Coronary Heart Disease Polygenic Risk Scores.评估冠心病多基因风险评分的性能和一致性。
JAMA. 2025 Jan 7;333(1):60-70. doi: 10.1001/jama.2024.23784.
2
Projected Changes in Statin and Antihypertensive Therapy Eligibility With the AHA PREVENT Cardiovascular Risk Equations.基于美国心脏协会 PREVENT 心血管风险方程的他汀类药物和抗高血压治疗适应证的预计变化。
JAMA. 2024 Sep 24;332(12):989-1000. doi: 10.1001/jama.2024.12537.
3
Integrative polygenic risk score improves the prediction accuracy of complex traits and diseases.
整合多基因风险评分可提高复杂性状和疾病的预测准确性。
Cell Genom. 2024 Apr 10;4(4):100523. doi: 10.1016/j.xgen.2024.100523. Epub 2024 Mar 19.
4
Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populations.选择、优化和验证十种用于美国不同人群临床应用的慢性病多基因风险评分。
Nat Med. 2024 Feb;30(2):480-487. doi: 10.1038/s41591-024-02796-z. Epub 2024 Feb 19.
5
Development and Validation of the American Heart Association's PREVENT Equations.美国心脏协会 PREVENT 方程的制定与验证。
Circulation. 2024 Feb 6;149(6):430-449. doi: 10.1161/CIRCULATIONAHA.123.067626. Epub 2023 Nov 10.
6
Pragmatic Approach to Applying Polygenic Risk Scores to Diverse Populations.应用多基因风险评分于不同人群的实用方法。
Curr Protoc. 2023 Nov;3(11):e911. doi: 10.1002/cpz1.911.
7
A multi-ancestry polygenic risk score improves risk prediction for coronary artery disease.多血统多基因风险评分可提高冠心病风险预测。
Nat Med. 2023 Jul;29(7):1793-1803. doi: 10.1038/s41591-023-02429-x. Epub 2023 Jul 6.
8
Returning integrated genomic risk and clinical recommendations: The eMERGE study.返回整合基因组风险和临床建议:eMERGE 研究。
Genet Med. 2023 Apr;25(4):100006. doi: 10.1016/j.gim.2023.100006. Epub 2023 Jan 6.
9
Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants.在超过 100 万名参与者中发现并系统地描述了冠心病的风险变异和基因。
Nat Genet. 2022 Dec;54(12):1803-1815. doi: 10.1038/s41588-022-01233-6. Epub 2022 Dec 6.
10
Advances and Applications of Polygenic Scores for Coronary Artery Disease.冠状动脉疾病多基因评分的进展与应用
Annu Rev Med. 2023 Jan 27;74:141-154. doi: 10.1146/annurev-med-042921-112629. Epub 2022 Oct 31.